ReviewMolecules (Basel, Switzerland)2022

Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review.

Vivek P Chavda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.